Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosis
Authors:
Open Access
- 16 September 2022
- Vol. 7 (5) , 100578
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma GroupEuropean Journal of Cancer, 2017
- Management of desmoid tumours: A nationwide survey of labelled reference centre networks in FranceEuropean Journal of Cancer, 2016
- Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosisEuropean Journal of Cancer, 2015
- Desmoid-Type Fibromatosis and PregnancyAnnals of Surgery, 2014
- Safety and efficacy of high‐dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II StudyPediatric Blood & Cancer, 2012
- Extension of the Cox Proportional Hazards Model for Time-Dependent Variables2011
- Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options.2010
- Expression Profiles of Sex Steroid Receptors in Desmoid TumorsThe Tohoku Journal of Experimental Medicine, 2006
- Estrogen receptor‐β expression in extraabdominal fibromatosesCancer, 2005
- Immunohistochemical analysis of desmoid tumoursJournal of Clinical Pathology, 2005